Log In
Print
BCIQ
Print
Print this Print this
 

Magellan autologous platelet gel

  Manage Alerts
Collapse Summary General Information
Company Arteriocyte Inc.
DescriptionAutologous platelet gel using Magellan Autologous Platelet Separator technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase I
Standard IndicationBurns
Indication DetailsTreat acute second and third degree burns; Treat thermal burn wounds
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today